Search

everythinglearnresearchcommunity

for

Search:↓

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Short-chain fatty acids from *Cutibacterium acnes* cause skin inflammation, contributing to acne.

The study found key genes and pathways involved in cashmere goat hair growth stages.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Botryococcus terribilis Ethanol Extract may reduce inflammation by changing gene expression in cells.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Hair can regrow in large wounds through a process similar to how hair forms in embryos, and understanding this could lead to new treatments for hair loss or scarring.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

Alitretinoin helped clear up a skin condition called generalized granuloma annulare in an elderly man.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

RANKL causes lymph nodes to grow by making certain cells multiply.

Activating Nrf2 in skin cells speeds up wound healing by increasing the growth of certain stem cells.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

White blood cells and their traps can slow down the process of new hair growth after a wound.

Neutrophils are key in causing chronic itch in atopic dermatitis, and blocking CXCR3 could reduce this itch.

Enhancing cannabinoid signaling may help treat skin inflammation.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

TRPV4 helps cells repair tissue and reduce scarring by controlling calcium levels.

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Inflammasome proteins can indicate the severity and treatment response of various diseases and injuries.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Human hair follicles produce and respond to erythropoietin, helping protect against stress.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.